Axsome Therapeutics Inc (AXSM)
$144.43 +0.68% Close Oct 30, 2026 Live
Axsome Therapeutics stock today
Axsome Therapeutics closed at $144.43 on October 30, 2026, up 0.68% on the day. Over the past year it returned +8.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $7.43 billion.
$150.00$200.00$250.00
NovJan 2026MarMayJulSep
| Period | AXSM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -21.7% | -0.9% |
| 3 months | -38.4% | +2.1% |
| Year to date | -20.9% | +11.7% |
| 1 year | +8.5% | +12.4% |
| 3 years | +140.6% | +88.5% |
| 5 years | +275.1% | +76.0% |
Key statistics
- Market value
- $7.43B
- Price / sales
- 9.6
- 52-week range
- $133.15 to $255.17
- Next report
- Nov 2, 2026
About Axsome Therapeutics
Axsome Therapeutics develops and commercializes therapies for psychiatric and neurological disorders.
Sector: Health Care
More on Axsome Therapeutics
- Financials: revenue, earnings and segmentsRevenue +66% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $21,023 today
No forecast, no recommendation. This page describes Axsome Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.